The study out of Vanderbilt University Medical Center found 14 percent of individuals with genetic variants impacting the kidney had kidney transplants and 10 percent with another variant had liver transplants. These transplants could have been avoided had the underlying genetic cause been disclosed.
Viz.AI's product uses a form of artificial intelligence to analyze computed tomography images of the brain to detect signs of a stroke.
Tucson, Arizona-based NuvOx Pharma has major plans for treating life-threatening hypoxia with a drug originally approved as a contrasting agent in Europe.
AiCure's tool uses a form of artificial intelligence for facial recognition to confirm that patients have taken the correct medication.
MedyMatch and NeuroLogica aim to improve the speed at which patients receive stroke treatment.
AliveCor also raised a $30 million Series D round led by Omron Healthcare and Mayo Clinic.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Golden Seeds led the round, and Kapor Capital?, Launchpad Venture Group?, Pond Capital and Community Health Network of Connecticut? also took part.
Dallas-based MicroTransponder is looking to treat neurological conditions with its aired Vagus Nerve Stimulation, which is designed to help patients with tinnitus as well as stroke victims.
Cadence Biomedical gets the thumbs up from a peer-reviewed publication concerning its Kickstart device.
They say that with a stroke, “time lost is brain lost” – so when a stroke happens, each second counts to stave off further brain damage. Seattle-area startup Cerevast Therapeutics is developing a device that emits ultrasound waves meant to quickly dislodge stroke-causing blood clots in the brain. And company just raised $10 million, according to a […]
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Cleveland Clinic released its top 10 medical innovations that it predicts to be gamechangers in 2015. During today’s conference, a group of 10 Cleveland Clinic doctors spoke on each disease, outlining why they were, indeed, innovative. Here’s some of the commentary around the much-anticipated Top 10: Given the huge interest in developing a vaccine for Ebola, […]
#MIS2014 Innovation #5 – antibody drug conjugates. Again! Idea around for 30 years, but antibodies better, humanized, understand targets. — Meghana Keshavan (@meghanakeshavan) October 29, 2014 The Cleveland Clinic just announced its top 10 medical innovations for 2015 – a long anticipated and often-prescient listing of the most gamechanging new health techs. This just in: […]
Ischemia Care, a Cincinnati-based company that combines bioinformatics and medical devices for stroke detection, is in the midst of raising up to $5 million, according to a filing with the SEC. So far, Ischemia Care, founded in 2009, has raised $1.9 million through equity offerings, with an additional $3.1 million to be sold, according to […]
Exithera Pharmaceuticals, a player in the anti-thrombosis and stroke prevention drug space, appears to be in the midst of a $9 million Series B round, according to regulatory filings. It has raised $3 million thus far, the filings said. Last we heard, the Westborough, Massachusetts company raised $2 million of a $4 million Series A […]
About half of all strokes could be caused by a narrowing of the carotid artery – the pipeline that ushers blood flow through the neck and to the brain. The Bay Area’s Silk Road Medical may have found a less-invasive way to increase the blood flow to the brain, using traditional stenting concepts but kicking ’em up a notch. […]